{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:26:18Z","timestamp":1775024778441,"version":"3.50.1"},"reference-count":24,"publisher":"BMJ","issue":"9","funder":[{"name":"a Grant-in-Aid for scientific research from the Ministry of Education, Science, Culture, and Sports of Japan."}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:sec><jats:title>Background\/aims<\/jats:title><jats:p>To investigate the efficacy of topical ganciclovir (GCV) for preventing disease recurrence and improving the surgical outcome post-Descemet\u2019s stripping automated endothelial keratoplasty (DSAEK) in patients with cytomegalovirus (CMV) endotheliitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This prospective, non-comparative case series study involved six eyes of six patients with endothelial decompensation due to CMV endotheliitis who underwent DSAEK, followed by a continuous, four to six times daily, topical administration of 0.5% GCV. Patient demographics, clinical history, and preoperative and postoperative examination (including any recurrence of CMV endotheliitis post-DSAEK), best corrected visual acuity (BCVA), intraocular pressure (IOP), graft survival rate and endothelial cell density (ECD) were examined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>No recurrence of CMV endotheliitis was detected post-DSAEK. The mean follow-up period was 40 months (range, 12\u201360 months). The mean preoperative BCVA was 1.52\u00b10.68\u2009LogMAR (range, 0.52\u20132.40 LogMAR), yet it had significantly improved to 0.15\u00b10.16\u2009LogMAR (range: \u22120.08 to 0.30 LogMAR) by 1\u2009year postoperative (P&lt;0.01). In all patients, IOP was well controlled (10\u201320\u2009mm Hg) postsurgery. The mean preoperative donor ECD was 2692\u00b1177 cells\/mm<jats:sup>2<\/jats:sup>, and the mean postoperative ECD was 1974, 1771 and 1174 cells\/mm<jats:sup>2<\/jats:sup> for the ECD loss of 26%, 33% and 54% at 6, 12 and 36 months, respectively. No adverse effects were observed associated with the long-term topical administration of GCV.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The continuous topical application of 0.5% GCV was found to be effective for preventing the recurrence of CMV endotheliitis, and it provided the optimal mid-term clinical outcomes post-DSAEK in patients with CMV endotheliitis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>UMIN000026746<\/jats:p><\/jats:sec>","DOI":"10.1136\/bjophthalmol-2017-311145","type":"journal-article","created":{"date-parts":[[2018,1,23]],"date-time":"2018-01-23T17:21:52Z","timestamp":1516728112000},"page":"1293-1297","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Topical ganciclovir treatment post-Descemet\u2019s stripping automated endothelial keratoplasty for patients with bullous keratopathy induced by cytomegalovirus"],"prefix":"10.1136","volume":"102","author":[{"given":"Koji","family":"Kitazawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Passara","family":"Jongkhajornpong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Inatomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanae","family":"Kayukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Wakimasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chie","family":"Sotozono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,1,23]]},"reference":[{"key":"2020050713020050000_102.9.1293.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.09.021"},{"key":"2020050713020050000_102.9.1293.2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2013-304625"},{"key":"2020050713020050000_102.9.1293.3","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/eye.2009.240","article-title":"Corneal endotheliitis with cytomegalovirus infection of corneal stroma","volume":"24","author":"Shimazaki","year":"2010","journal-title":"Eye"},{"key":"2020050713020050000_102.9.1293.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.11.026"},{"key":"2020050713020050000_102.9.1293.5","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-013-0268-2"},{"key":"2020050713020050000_102.9.1293.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.04.053"},{"key":"2020050713020050000_102.9.1293.7","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-308238"},{"key":"2020050713020050000_102.9.1293.8","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-011-1813-7"},{"key":"2020050713020050000_102.9.1293.9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1442-9071.2012.02888.x","article-title":"Topical ganciclovir treatment in patients with cytomegalovirus endotheliitis receiving penetrating keratoplasty","volume":"41","author":"Su","year":"2013","journal-title":"Clin Exp Ophthalmol"},{"key":"2020050713020050000_102.9.1293.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.10.031"},{"key":"2020050713020050000_102.9.1293.11","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307390"},{"key":"2020050713020050000_102.9.1293.12","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2016-309650"},{"key":"2020050713020050000_102.9.1293.13","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.126.8.1133"},{"key":"2020050713020050000_102.9.1293.14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.ophtha.2016.11.001","article-title":"Cystoid macular edema after descemet\u2019s stripping automated endothelial keratoplasty","volume":"124","author":"Kitazawa","year":"2017","journal-title":"Ophthalmology"},{"key":"2020050713020050000_102.9.1293.15","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31802d82fa"},{"key":"2020050713020050000_102.9.1293.16","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ajo.2014.08.007","article-title":"Clinical outcomes in cytomegalovirus-positive posner-schlossman syndrome patients treated with topical ganciclovir therapy","volume":"158","author":"Su","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"2020050713020050000_102.9.1293.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.07.036"},{"key":"2020050713020050000_102.9.1293.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.08.007"},{"key":"2020050713020050000_102.9.1293.19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.ophtha.2016.03.011","article-title":"Descemet stripping endothelial keratoplasty: ten-year endothelial cell loss compared with penetrating keratoplasty","volume":"123","author":"Price","year":"2016","journal-title":"Ophthalmology"},{"key":"2020050713020050000_102.9.1293.20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/ICO.0000000000000028","article-title":"Outcomes after DSEK in 101 eyes with previous trabeculectomy and tube shunt implantation","volume":"33","author":"Aldave","year":"2014","journal-title":"Cornea"},{"key":"2020050713020050000_102.9.1293.21","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000170"},{"key":"2020050713020050000_102.9.1293.22","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1001\/jamaophthalmol.2014.3923","article-title":"Factors associated with corneal graft survival in the cornea donor study","volume":"133","author":"Sugar","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"2020050713020050000_102.9.1293.23","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1177\/112067210501500512","article-title":"High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela","volume":"15","author":"Arevalo","year":"2005","journal-title":"Eur J Ophthalmol"},{"key":"2020050713020050000_102.9.1293.24","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ajo.2011.09.010","article-title":"Clinical outcomes in patients with cytomegalovirus retinitis treated with ganciclovir implant","volume":"153","author":"Oktavec","year":"2012","journal-title":"Am J Ophthalmol"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2017-311145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:56:14Z","timestamp":1601110574000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2017-311145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,23]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,8,17]]},"published-print":{"date-parts":[[2018,9]]}},"alternative-id":["10.1136\/bjophthalmol-2017-311145"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2017-311145","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,23]]}}}